Fritextsökning
Innehållstyper
-
Björn Eriksson – Hjärtläkaren i stormens öga
”Stormen är här”, meddelade sjukvårdsdirektören Björn Eriksson i mars förra året och fick uppleva en vår han helst hade varit utan. Nu är han ny generaldirektör...
-
Vattenfall is firing with biomass
Vattenfall will provide Denmark with electricity by means of biomass.
-
Ny utbildning för receptarier i Skåne
Löser bristen på farmaceuter i regionen med ny utbildning.
-
New influenza vaccine to EU
The Astrazeneca subsidary Medimmune submits marketing authorisationapplication in EU for an new intranasal vaccine against influenza.
-
Academia - a strong player on the lab market
While the industry was short of money during the financial crisis, government incentives were in full swing in Sweden during 2009. - Our sales to academia incre...
-
Årets fusion
Flera bolag har gått ihop under året. Här är några av dem.
-
EU grants project on toxicity of nanomaterials
A multinational research project has have been awarded EUR 3 358 500 from the European Commission to study the hazardous effects of engineered nanomaterials on ...
-
New study of toxins and heart disease
Is there a correlation between exposure to hormone interfering environmental toxins and increased risk of developing cardiovascular disease? A new patient study...
-
Novo och Astra ligger bra till i internationell kraftmätning
Patentutgångar kommer under de närmaste åren att drabba flera stora läkemedelsbolag, men Astrazeneca och Novo Nordisk hör till de som skymtar ljusglimtar enligt en analys.
-
Medicult acquires embryo scanner
The Danish company Medicult signs an agreement with Novocellus to gain access to embryo selection technology.
-
Changing e-solutions for clinical trials
Social media and personalized medicine are two factors that will have a great impact on the design and IT-solutions for clinical trials. Unithink is an upcoming...
-
Pfizer lays a chunky bid on Wyeth
The merger of two pharma giants is the largest industry deal so far this year. Pfizer will acquire Wyeth in a cash-and-stock transaction currently valued at app...
-
Bio engineering breakthrough in Denmark
Brand new research makes BioGasol's cellulosic ethanol process even more competitive.
-
Millnert lämnar Vetenskapsrådet
Generaldirektören avgår. Lämnar uppdraget den 1 december.
-
Success fee to Bioinvent and partner
The cancer collaboration started last year. After successful technology transfer the two partner companies now receives 5 million euro from pharma giant Roche.
-
Nytt bolag till inkubator på Medicon Village
E-hälsobolaget Instant Advice flyttar nu in på LundLSI på Medicon Village.
-
Eli Lilly writes biotech fine history
The American biotech company Eli Lilly will pay US 1.415 billion to resolve allegations of off-label promotion of a dementia drug.
-
First ever study of human stem cell treatment
The FDA says yes to the world's first study in man of a human embryonic stem cell based therapy to treat spinal injury.
-
Martin Ingvar ny styrelsetopp i Forte
Det nya forskningsinstitutet rekryterar neuroprofessor.
-
Control of blood vessels can treat obesity
Mice exposed to low temperatures develop more blood vessels in their adipose tissue and metabolise body fat more quickly, according to a new study from Karolinska Institutet.
-
Enas mot resistensen
I en ny deklaration går branschen samman kring tre fokusområden där åtgärder krävs för att motarbeta den ökande antibiotikaresistensen i världen.
-
Reproducibility and handling in focus with new electronic pipette
The Eppendorf Xplorer electronic pipette has been developed with reproducibility in mind.
-
Measurement of calorific content in a matter of minutes
The AC600 calorimeter from Leco uses rapid thermodynamics to analyze calorific content in five minutes.
-
Detta krävs i valideringsprocessen
För att få producera ett läkemedel krävs en dokumenterad valideringsprocess. Det är tillverkarens ansvar att valideringen utförs enligt gällande krav för good m...
BREAKING